CTNM
Price
$14.53
Change
+$0.34 (+2.40%)
Updated
Aug 17 closing price
Capitalization
545.88M
Earnings call today
Intraday BUY SELL Signals
ZURA
Price
$5.68
Change
+$0.11 (+1.97%)
Updated
Aug 17 closing price
Capitalization
543.35M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTNM vs ZURA

CTNM vs ZURA Comparison Chart in %
View a ticker or compare two or three
VS
CTNM vs. ZURA commentary
Aug 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and ZURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2026
Stock price -- (CTNM: $14.53 vs. ZURA: $5.68)
Brand notoriety: CTNM and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 524% vs. ZURA: 32%
Market capitalization -- CTNM: $545.88M vs. ZURA: $543.35M
CTNM [@Biotechnology] is valued at $545.88M. ZURA’s [@Biotechnology] market capitalization is $543.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $130.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than CTNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 2 TA indicator(s) are bullish while ZURA’s TA Score has 3 bullish TA indicator(s).

  • CTNM’s TA Score: 2 bullish, 5 bearish.
  • ZURA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ZURA is a better buy in the short-term than CTNM.

Price Growth

CTNM (@Biotechnology) experienced а +0.28% price change this week, while ZURA (@Biotechnology) price change was +0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.12%. For the same industry, the average monthly price growth was +0.13%, and the average quarterly price growth was +2708.80%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 18, 2026.

ZURA is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+0.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($546M) and ZURA($543M) have the same market capitalization . CTNM has higher P/E ratio than ZURA: CTNM (26.40) vs ZURA (7.96). CTNM YTD gains are higher at: 27.122 vs. ZURA (8.397). CTNM has higher annual earnings (EBITDA): -66M vs. ZURA (-81.44M). CTNM (237M) and ZURA (226M) have equal amount of cash in the bank . CTNM (0) and ZURA (0) have equivalent revenues.
CTNMZURACTNM / ZURA
Capitalization546M543M101%
EBITDA-66M-81.44M81%
Gain YTD27.1228.397323%
P/E Ratio26.407.96332%
Revenue00-
Total Cash237M226M105%
Total Debt6.57MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CTNMZURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
61%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
61%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
57%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
52%
Aroon
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signal:
Gain/Loss:
ZURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOVLX59.93N/A
N/A
Homestead Value
FAZYX16.16N/A
N/A
Fidelity Advisor Multi-Asset Income M
OBIIX12.69N/A
N/A
Oberweis International Opps Instl
ETCEX17.61N/A
N/A
Eventide Exponential Technologies C
JRANX97.58-0.10
-0.10%
Janus Henderson Research N

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with PMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+2.40%
PMN - CTNM
34%
Loosely correlated
-1.35%
ZURA - CTNM
33%
Loosely correlated
+1.97%
PHVS - CTNM
32%
Poorly correlated
+0.51%
ZBIO - CTNM
29%
Poorly correlated
+3.35%
GPCR - CTNM
29%
Poorly correlated
-1.38%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
+1.97%
VIR - ZURA
43%
Loosely correlated
+1.62%
CRBU - ZURA
42%
Loosely correlated
-0.63%
RCUS - ZURA
42%
Loosely correlated
+0.27%
BCAX - ZURA
40%
Loosely correlated
+2.72%
FDMT - ZURA
38%
Loosely correlated
+19.32%
More